WO2002081658A8 - Transgenic mice containing cacnb4 calcium ion channel gene disruptions - Google Patents

Transgenic mice containing cacnb4 calcium ion channel gene disruptions

Info

Publication number
WO2002081658A8
WO2002081658A8 PCT/US2002/009850 US0209850W WO02081658A8 WO 2002081658 A8 WO2002081658 A8 WO 2002081658A8 US 0209850 W US0209850 W US 0209850W WO 02081658 A8 WO02081658 A8 WO 02081658A8
Authority
WO
WIPO (PCT)
Prior art keywords
transgenic mice
calcium ion
ion channel
mice containing
gene disruptions
Prior art date
Application number
PCT/US2002/009850
Other languages
French (fr)
Other versions
WO2002081658A2 (en
WO2002081658A3 (en
Inventor
Keith D Allen
Original Assignee
Deltagen Inc
Keith D Allen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deltagen Inc, Keith D Allen filed Critical Deltagen Inc
Priority to AU2002258659A priority Critical patent/AU2002258659A1/en
Publication of WO2002081658A2 publication Critical patent/WO2002081658A2/en
Publication of WO2002081658A3 publication Critical patent/WO2002081658A3/en
Publication of WO2002081658A8 publication Critical patent/WO2002081658A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knockout animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Abstract

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising mutations in a CACNB4 gene. Such transgenic mice are useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions.
PCT/US2002/009850 2001-03-29 2002-03-29 Transgenic mice containing cacnb4 calcium ion channel gene disruptions WO2002081658A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002258659A AU2002258659A1 (en) 2001-03-29 2002-03-29 Transgenic mice containing cacnb4 calcium ion channel gene disruptions

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US28056101P 2001-03-29 2001-03-29
US60/280,561 2001-03-29
US28860001P 2001-05-03 2001-05-03
US60/288,600 2001-05-03
US10653202A 2002-03-28 2002-03-28
US10/106,532 2002-03-28

Publications (3)

Publication Number Publication Date
WO2002081658A2 WO2002081658A2 (en) 2002-10-17
WO2002081658A3 WO2002081658A3 (en) 2003-12-11
WO2002081658A8 true WO2002081658A8 (en) 2004-04-22

Family

ID=29715988

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/009850 WO2002081658A2 (en) 2001-03-29 2002-03-29 Transgenic mice containing cacnb4 calcium ion channel gene disruptions

Country Status (2)

Country Link
AU (1) AU2002258659A1 (en)
WO (1) WO2002081658A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation

Also Published As

Publication number Publication date
WO2002081658A2 (en) 2002-10-17
AU2002258659A1 (en) 2002-10-21
WO2002081658A3 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
WO2002079440A8 (en) Transgenic mice containing gpcr5-1 gene disruptions
WO2002079424A3 (en) TRANSGENIC MICE CONTAINING β3GALT2 GENE DISRUPTIONS
WO2002046390A3 (en) Transgenic mice containing rptpb tyrosine phosphatase gene disruptions
WO2002079438A3 (en) Ogri gene disruptions, compositions and methods relating thereto
WO2002079444A3 (en) Transgenic mice containing msk2 serine/threonine kinase gene disruptions
WO2003026395A3 (en) Mo54 gene disruptions, compositions and methods related thereto
WO2002081658A8 (en) Transgenic mice containing cacnb4 calcium ion channel gene disruptions
WO2002045498A3 (en) Transgenic mice containing channel protein target gene disruptions
WO2002003789A3 (en) Transgenic mice containing targeted gpcr gene disruptions
WO2002048345A3 (en) Transgenic mice containing glutamate receptor (grik5) gene disruptions
WO2002040662A3 (en) Transgenic mice containing targeted gene disruptions
WO2002079414A8 (en) Transgenic mice containing clcn7 chloride channel gene disruptions
WO2002001950A3 (en) Transgenic mice containing targeted gene disruptions
WO2002079433A3 (en) Transgenic mice containing tmem3 beta-1,3-n-acetylglucosaminyltransferase gene disruptions
WO2002003788A3 (en) Transgenic mice containing targeted phosphatase gene disruptions
WO2002003793A3 (en) Transgenic mice containing targeted gene disruptions
WO2003026403A3 (en) Ctsz disruptions, compositions and methods relating thereto
WO2002079425A3 (en) Transgenic mice containing clcn4 chloride ion channel gene disruptions
WO2002079412A3 (en) Transgenic mice containing usp3-like deubiquitinating enzyme gene disruptions
WO2002048346A3 (en) Transgenic mice containing bsmap gene disruptions
WO2002003787A3 (en) Transgenic mice containing targeted gene disruptions
WO2002079446A3 (en) Transgenic mice containing gpr31 gene disruptions
WO2002055687A3 (en) Transgenic mice containing target gene disruptions
WO2002045500A3 (en) Transgenic mice containing ptp36 tyrosine phosphatase disruptions
WO2002045492A3 (en) Transgenic mice containing polycystin-related gene disruptions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WR Later publication of a revised version of an international search report
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP